An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

One in eight men in the United States will be diagnosed with prostate cancer in their lifetime. The prostate is a gland in the male reproductive system that produces seminal fluid. Prostate cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. A landmark trial aiming to shape the future of prostate cancer screening in the UK has begun testing a group of men considered to ...

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

As reports surface that the UK’s national screening committee are set to reject proposals for any national prostate screening programme, experts warn that the decision, if followed through with, puts ...

The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation. The £42m trial is being co-led by UCL, ...